淀粉样蛋白病理调节老年非痴呆者轻微抑郁症状与认知损害的关联
BACKGROUND: The relationship between depression and Alzheimer's disease (AD) is complex and still not well understood. We aimed to examine the roles of the AD core pathologies in modulating the associations of minimal depressive symptoms (MDSs) with cognitive impairments.…
要点
- MDS与较差整体认知和更高淀粉样蛋白负荷相关。
- 淀粉样蛋白病理部分中介MDS对认知的影响,最高达85%。
- MDS与AD痴呆风险增加83%相关(HR=1.83)。
核心结论
- 淀粉样蛋白病理可能部分中介并放大MDS对认知损害和AD风险的影响。
研究设计与样本
- CABLE队列纳入721名有认知、抑郁症状和脑脊液AD生物标志物数据的参与者,进行因果中介分析(10,000次bootstrap迭代)。
- ADNI队列纳入725名非痴呆老年人(平均年龄73.5±6.9岁,女性301名[42%]),用于重复中介效应并检验纵向关系。
主要发现
- MDS对认知的影响被淀粉样蛋白病理部分中介,中介比例最高达85%。
- 在ADNI中重复了中介效应,整体认知、记忆和执行功能的中介百分比为10%至30%。
临床怎么用
- 对老年非痴呆者,轻微抑郁症状应视为认知损害和AD风险的潜在早期标志,而非仅情绪问题。
- 评估轻微抑郁症状时,可结合淀粉样蛋白病理标志物进行风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The relationship between depression and Alzheimer's disease (AD) is complex and still not well understood. We aimed to examine the roles of the AD core pathologies in modulating the associations of minimal depressive symptoms (MDSs) with cognitive impairments. METHODS: A total of 721 participants who had measures of cognition, depressive symptoms, and cerebrospinal fluid AD biomarkers were included from the CABLE (Chinese Alzheimer's Biomarker and LifestylE) study. Causal mediation analyses with 10,000 bootstrapped iterations were conducted to explore the mediation effects of AD pathologies on cognition. The ADNI (Alzheimer's Disease Neuroimaging Initiative) was used 1) to replicate the mediation effects and 2) to examine the longitudinal relationships of MDSs with amyloid pathology and incident AD risk. RESULTS: In CABLE, MDSs were associated with poorer global cognition (p = .006) and higher amyloid burden as indicated by cerebrospinal fluid amyloid markers (p < .0001). The influence of MDSs on cognition was partially mediated by amyloid pathology (a maximum of 85%). The mediation effects were replicated in 725 elderly persons without dementia (age, mean ± SD = 73.5 ± 6.9 years; 301 female subjects [42%]) in ADNI, such that the mediation percentage varied from 10% to 30% for general cognition, memory, and executive functions. Longitudinal analyses revealed a bidirectional relationship between MDSs and amyloid pathology (p = .01). MDSs were associated with 83% increased risk of developing AD dementia (hazard ratio = 1.83, p < .01). CONCLUSIONS: Overall, amyloid pathology might partially mediate and magnify the influences of MDSs on cognitive impairments and AD risk.
引用
- Xu W, Feng W, Shen XN, et al. Amyloid Pathologies Modulate the Associations of Minimal Depressive Symptoms With Cognitive Impairments in Older Adults Without Dementia. Biol Psychiatry. 2020. PMID: 32980133. doi:10.1016/j.biopsych.2020.07.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。